Take a look at the beta version of dw.com. We're not done yet! Your opinion can help us make it better.
Messenger RNA vaccines can theoretically be adapted to keep pace with a mutating pathogen. But a booster with the existing formulation already kicks the immune response in recipients back up to very high levels of protection, also against delta.